There have been 50 recent insider transactions recorded for Adaptive Biotechnologies Corporation (ADPT), including 16 buys and 34 sells. Total insider buying was valued at $288.47K and total insider selling at $14.16M.
Notable insiders with recent activity include Rubinstein Julie, Griffin Michelle Renee, Robins Chad M. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — ADPT
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-04-02 |
Rubinstein Julie |
President and COO |
Option Exercise (Sell) |
14,722 |
$7.27 |
$107.03K |
81,719 |
| 2026-04-01 |
Rubinstein Julie |
President and COO |
Option Exercise (Sell) |
14,722 |
$7.27 |
$107.03K |
96,441 |
| 2026-03-31 |
Rubinstein Julie |
President and COO |
Option Exercise (Sell) |
14,722 |
$7.27 |
$107.03K |
111,163 |
| 2026-03-30 |
Rubinstein Julie |
President and COO |
Option Exercise (Sell) |
14,722 |
$7.27 |
$107.03K |
125,885 |
| 2026-03-27 |
Rubinstein Julie |
President and COO |
Option Exercise (Sell) |
14,722 |
$7.27 |
$107.03K |
140,607 |
| 2026-03-26 |
Rubinstein Julie |
President and COO |
Option Exercise (Sell) |
14,722 |
$7.27 |
$107.03K |
155,329 |
| 2026-03-25 |
Rubinstein Julie |
President and COO |
Option Exercise (Sell) |
14,722 |
$7.27 |
$107.03K |
170,051 |
| 2026-03-24 |
Rubinstein Julie |
President and COO |
Option Exercise (Sell) |
14,722 |
$7.27 |
$107.03K |
184,773 |
| 2026-03-23 |
Rubinstein Julie |
President and COO |
Option Exercise (Sell) |
14,722 |
$7.27 |
$107.03K |
199,495 |
| 2026-03-20 |
Rubinstein Julie |
President and COO |
Option Exercise (Sell) |
3,939 |
$6.55 |
$25.8K |
- |
| 2026-03-19 |
Rubinstein Julie |
President and COO |
Option Exercise (Sell) |
14,722 |
$6.55 |
$96.43K |
3,939 |
| 2026-03-18 |
Rubinstein Julie |
President and COO |
Option Exercise (Sell) |
14,722 |
$6.55 |
$96.43K |
18,661 |
| 2026-03-17 |
Rubinstein Julie |
President and COO |
Option Exercise (Sell) |
14,722 |
$6.55 |
$96.43K |
33,383 |
| 2026-03-16 |
Rubinstein Julie |
President and COO |
Option Exercise (Sell) |
14,722 |
$6.55 |
$96.43K |
48,105 |
| 2026-03-13 |
Rubinstein Julie |
President and COO |
Option Exercise (Sell) |
14,722 |
$6.55 |
$96.43K |
62,827 |
| 2026-03-12 |
Rubinstein Julie |
President and COO |
Option Exercise (Sell) |
14,722 |
$6.55 |
$96.43K |
77,549 |
| 2026-03-11 |
Griffin Michelle Renee |
Director |
Informative Sell |
15,394 |
$13.91 |
$214.13K |
15,625 |
| 2026-03-11 |
Robins Chad M |
CEO and Chairman |
Informative Sell |
329,600 |
$13.17 |
$4.34M |
2,301,113 |
| 2026-03-11 |
Lo Francis |
Chief People Officer |
Informative Sell |
30,593 |
$14.08 |
$430.75K |
291,374 |
| 2026-03-11 |
Piskel Kyle |
Chief Financial Officer |
Informative Sell |
18,672 |
$13.17 |
$245.91K |
259,840 |
| 2026-03-11 |
Rubinstein Julie |
President and COO |
Option Exercise (Sell) |
14,722 |
$6.55 |
$96.43K |
92,271 |
| 2026-03-11 |
Robins Harlan S |
Chief Scientific Officer |
Informative Sell |
329,600 |
$13.17 |
$4.34M |
1,522,058 |
| 2026-03-11 |
Benzeno Sharon |
Chief Commercial Ofc Imm Med |
Informative Sell |
63,103 |
$13.17 |
$831.07K |
272,751 |
| 2026-03-11 |
Bobulsky Susan |
Chief Commercial Officer, Mrd |
Informative Sell |
41,338 |
$13.17 |
$544.42K |
427,775 |
| 2026-03-10 |
Rubinstein Julie |
President and COO |
Option Exercise (Sell) |
14,722 |
$6.55 |
$96.43K |
106,993 |
| 2026-03-09 |
Rubinstein Julie |
President and COO |
Option Exercise (Sell) |
14,722 |
$6.55 |
$96.43K |
121,715 |
| 2026-03-06 |
Robins Chad M |
CEO and Chairman |
RSU Award |
709,220 |
- |
- |
2,771,280 |
| 2026-03-06 |
Robins Harlan S |
Chief Scientific Officer |
RSU Award |
709,220 |
- |
- |
1,992,324 |
| 2026-03-06 |
Rubinstein Julie |
President and COO |
Option Exercise (Sell) |
14,722 |
$6.55 |
$96.43K |
136,437 |
| 2026-03-05 |
Lo Francis |
Chief People Officer |
Informative Sell |
38,074 |
$15.09 |
$574.54K |
321,967 |
| 2026-03-04 |
Rubinstein Julie |
President and COO |
Option Exercise |
11,881 |
$12.14 |
$144.24K |
610,514 |
| 2026-03-04 |
Griffin Michelle Renee |
Director |
RSU Award |
15,625 |
- |
- |
31,019 |
| 2026-03-04 |
Neupert Peter M |
Director |
RSU Award |
15,625 |
- |
- |
240,315 |
| 2026-03-04 |
Hershberg Robert |
Director |
RSU Award |
15,625 |
- |
- |
62,347 |
| 2026-03-04 |
Robins Chad M |
CEO and Chairman |
RSU Award |
127,813 |
- |
- |
2,062,060 |
| 2026-03-04 |
Lo Francis |
Chief People Officer |
RSU Award |
44,063 |
- |
- |
360,041 |
| 2026-03-04 |
Piskel Kyle |
Chief Financial Officer |
RSU Award |
61,875 |
- |
- |
278,512 |
| 2026-03-04 |
Rubinstein Julie |
President and COO |
RSU Award |
81,250 |
- |
- |
656,485 |
| 2026-03-04 |
Robins Harlan S |
Chief Scientific Officer |
RSU Award |
127,813 |
- |
- |
1,283,104 |
| 2026-03-04 |
Benzeno Sharon |
Chief Commercial Ofc Imm Med |
RSU Award |
39,063 |
- |
- |
335,854 |
| 2026-03-04 |
Bobulsky Susan |
Chief Commercial Officer, Mrd |
RSU Award |
59,375 |
- |
- |
406,613 |
| 2026-03-04 |
Owen Katey Einterz |
Director |
RSU Award |
15,625 |
- |
- |
88,254 |
| 2026-03-03 |
Griffin Michelle Renee |
Director |
Option Exercise (Sell) |
48,044 |
$3.99 |
$191.7K |
- |
| 2026-03-03 |
Rubinstein Julie |
President and COO |
Option Exercise |
11,881 |
$12.14 |
$144.24K |
614,852 |
| 2025-05-16 |
Piskel Kyle |
Chief Financial Officer |
Informative Sell |
1,929 |
$8.89 |
$17.15K |
277,396 |
| 2025-05-16 |
Piskel Kyle |
Chief Financial Officer |
Informative Sell |
1,929 |
$8.89 |
$17.15K |
269,581 |
| 2025-05-15 |
Piskel Kyle |
Chief Financial Officer |
RSU Award |
7,815 |
- |
- |
279,325 |
| 2025-05-01 |
Robins Harlan S |
Chief Scientific Officer |
Option Exercise (Sell) |
68,412 |
$6.32 |
$432.36K |
- |
| 2025-03-24 |
Robins Harlan S |
Chief Scientific Officer |
Option Exercise (Sell) |
1,698 |
$6.32 |
$10.73K |
68,412 |
| 2025-03-14 |
Piskel Kyle |
Chief Financial Officer |
Option Exercise (Sell) |
2,500 |
$6.32 |
$15.8K |
- |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
